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Summary: The ﬁeld of spine surgery has many controversies. The surgical
treatment of the sacroiliac (SI) joint is, too, fraught with debate. The
diagnosis of painful SI joints is currently limited to relief following
“diagnostic” injections and pain generated from a suite of clinical maneu-
vers. Diagnoses of SI joint dysfunction are dependent entirely on patient-
reported responses to provocative maneuvers and invasive procedures.
There is a glaring lack of objective radiographic and objective physical
examination ﬁndings for this syndrome. The evidence for treatment, and
speciﬁcally for the surgical treatment of the SI joint is reviewed and cri-
tiqued. Although the surgical techniques are simple, consensus is elusive for
both indication and optimal technique. Ethical principles for surgical
innovation and practical considerations for the treatment of the SI joint
syndrome are discussed at length. Discussed as well are key points to
consider when providing informed consent to a patient before proceeding
with surgical intervention for this procedure and diagnosis. Spine surgery is
a ﬁeld with considerable regional variation in practice. Even today, the
precise indications for arthrodesis, extent, and approach, remain frequently
debated; however, as much conversation takes place surrounding lumbar
surgery, even more confusion, bias, opinion, and deliberation exists when
surgical treatment of the SI joint is considered. This chapter discusses the
unique challenges associated with the SI joint and provides practical con-
siderations for the treatment thereof.
Key Words: SI joint syndrome—SI joint fusion—ethics—low back
pain.
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KEY POINTS
 Diagnosis of painful sacroiliac (SI) joints is currently limited
to relief following “diagnostic” injections and pain generated
from a suite of clinical maneuvers.1
 Diagnoses of SI joint dysfunction are dependent entirely on
patient-reported responses to provocative maneuvers and
invasive procedures and lacks objective radiographic ﬁnd-
ings or objective physical examination ﬁndings.
 Caution must be applied in interpreting “evidence” for
surgical “fusion” of the SI joint.
 Surgical techniques for this procedure are simple, yet
consensus on clear indications and optimal technique remain
elusive.
 Ethical principles and practical considerations for the
treatment of SI joint syndrome are discussed.
INTRODUCTION
As the US population ages with an estimated 1000 people
enrolling in Medicare daily,2 the incidence and prevalence of
symptomatic complaints related to aging are dramatically
increasing in all aspects of health care. Low back pain, a fated
result of bipedal human evolution, is often encountered and,
frequently, inadequately recognized and treated in primary care
and subspecialty clinics. Because of the exquisitely engineered
function and interplay of the axial and appendicular skeleton,3,4
in the absence of nerve compression or frank bony instability
with the host of supporting soft tissues and nervous control,
accurate diagnosis of the etiology of the pain becomes
problematic.
The diagnostic algorithm for etiologies of low back pain
often includes an assessment for radicular symptoms due to
nerve root compression5 or claudicatory symptoms from central
spinal stenosis. After those classic diagnoses, diagnosis
becomes poachy with a poor signal to noise ratio. Identiﬁcation
of symptomatic patterns through clinical evaluation, both his-
tory and examination,6 become the lanterns by which the fog of
subjective data are illuminated. The most astute clinician must
navigate the murky balance between discogenic back pain and
asymptomatic radiographic degeneration, facetogenic back
pain, and asymptomatic age-appropriate changes, and
symptomatic or asymptomatic pars interarticularis defects.
Despite the controversy in treating those diagnoses surgically,
degenerative disc disease, facet arthrosis, and pars defects can
all be identiﬁed through objective radiographic imaging. What
separates the SI joint from these potential pain generators is the
current lack of reliable radiographic ﬁndings that can be used to
rule out SI joint dysfunction as a diagnosis. The phrase “dys-
function” captures the challenge that surgeons face in managing
SI joint pain. Pain, purely a patient’s subjective experience,
must be taken at truth. However, dysfunction implies an injury
that responds to surgery. Thus, as surgeons, we are not merely
working to identify SI joint pain—we are working to identify SI
joint pain where the beneﬁts of interventions, such as surgery,
outweigh the potential risks.
Before further discussion of the SI joint, historical
examination of the management of lumbar disc herniations can
be instructive for parallel comparison. Lumbar radiculopathy
from disc herniation is a condition in the general parlance and is
a staple of the anatomy curriculum taught to ﬁrst-year medical
students. Among spine surgeons, few would criticize a
“standard” open discectomy with examination of the nerve root
as a reasonable approach to management of a symptomatic
lumbar disc herniation. The natural history and surgical out-
comes for primary lumbar disc herniation has been well
studied.7 Relying on this extensive body of literature and
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clinical experience, spine surgeons can offer a concise and
considered informed consent highlighting the pertinent, rea-
sonably foreseeable risks, beneﬁts, and alternatives of surgery
versus nonsurgical management.
This clean, concise approach, however, was not always
the standard of care. In the 1950s, debate raged over whether
fusion was indicated in the treatment of ruptured intervertebral
discs. Conservative neurosurgeons advocated for simple
removal of the herniated disc fragment when leg pain pre-
dominated symptomatology, while orthopedic spine surgeons
countered by arguing for bony fusion in conjunction with
fragmentectomy. Dr Ralph Cloward,8 an eminent and pio-
neering forefather of spine surgery, wrote “all lumbar disc
operations should be accompanied by a spinal fusion.” Before
Cloward and his contemporaries in the 1950s, the treatment of
intervertebral disc herniation into the spinal canal might have
been approached with a transdural approach! Mixter and Ayer9
report in a 1935 New England Journal of Medicine article an
approach for disc herniation with a laminectomy that “may be
limited to two or three vertebrae … removing the articular
facets to give wider exposure.” The authors note that “It is
sometimes necessary to remove part of one pedicle … at other
times it is easier to open the dura and then incise it again over
the lesion.” Although the transdural approach to decompression
of a hernieated disc is clearly archaic and is often met with
disbelief when discovered by the young surgeon, even the
surgeons in the era of the Great Depression could rely on ﬂu-
oroscopic myelography to provide objectively veriﬁable evi-
dence of a disc herniation. Thus, it is likely that the SI joint is
the only anatomic region of the spine that a neurosurgeon or
orthopedic spine surgeon considers operating on in the absence
of a clear radiographic ﬁnding. This uncertainty should be of
concern to both surgeons and patients. Nevertheless, just as the
patient in 1935 had to accept that state of the art treatment for a
disc herniation involved excision of a pedicle and a transdural
approach, if SI joint dysfunction truly exists, patients in 2018
have to accept the reality of the state-of-the-art in 2018 when
considering their options.
Thus, the ethics and debate can be distilled down to 2
questions.
(1) Is SI joint dysfunction a “real” problem with a physical or
biochemical nature?
(2) Knowing that minimally invasive surgical (MIS) treatment
for SI joint syndrome is in its infancy, how should patients
be ethically counseled on the available treatment options?
DIAGNOSING SI JOINT SYNDROME IN 2018
Dysfunction of the SI joint as an etiology of low back pain
has emerged as somewhat of a cause celebre, despite its rela-
tively low prevalence10–15 (10% to 30%) and diagnostic difﬁ-
culty. A clinical history of buttock pain with low back pain is
reported in up to 95% of patients diagnosed with SI joint
syndrome16 and, illustrating the extent of the diagnostic fen,
other studies report patients denying lumbar pain as part of their
symptomology.3 These contradictory clinical histories highlight
the nonspeciﬁc nature of the complaints and point to other
etiologies apart from the SI joint6—soft tissue damage or
dysfunction come to mind. Patients with pain in the region SI
joint may have multiple etiologies to account for these symp-
toms. The lack of pathognomonic symptomatology clearly
identifying the SI joint as the pain generator is critical to con-
sider, and should engender caution, perhaps even reticence,
when a diagnosis is being made. Some of the clinical
maneuvers used during physical examination (Table 1) to
diagnose SI joint syndrome overlap with degenerative hip dis-
ease and are in themselves nonspeciﬁc.3,5,6,11 Imaging criteria17
and intra-articular injections18–20 historically have failed to
provide an assuring underpinning to the diagnosis (and in the
context of open surgery) leaving the clinician with focal joint
pain,21 localized to the sacral ala, as the sole criteria from which
to launch a treatment plan.
In the present day, SI joint diagnosis has some parallels to
the diagnosis of other clinical syndromes for which the patho-
genesis is unclear or ill-deﬁned, and symptomatology or history
overwhelm any objective measurements. Patient suffering is
evident in these syndromes, yet there are no objective tests—
imaging, laboratory, or provocative—to conﬁrm diagnosis.
Fibromylagia is perhaps 1 such clinical syndrome that is
familiar to the neurosurgeon or orthopedic surgeon. Classiﬁed
as a rheumatologic disease, ﬁbromyalagia requires no objective
tests for diagnosis as laboratory values, imaging studies, and
histopathology can all be normal. Its diagnosis is made through
matching clinical history and a minimum number of tender
points on clinical examination to a list of diagnostic criteria,
constructed by physicians.22–24 There is a constellation of
minor criteria of nonspeciﬁc symptoms associated with the
syndrome as well.23 The natural history of this syndrome is
physically benign in that there is no abnormal development of
arthritis or deterioration of musculoskeletal function that occurs
and treatments are medical therapies mostly targeted at
norepinephrine, serotonin, and GABA neurotransmission;
cognitive behavioral therapies are also recommended, and
therapies have similar, minimally or moderately effective,
results.24,25 However, new research is evolving that may pro-
vide better insight into an objective diagnosis of ﬁbromyalgia.
Small studies have shown that circulating microRNA proﬁles
differ between patients with ﬁbromyalgia and age-matched and
sex-matched controls.26 Genome-wide expression proﬁling of
patients with ﬁbromyalgia have shown differential expression
of genes associated with pain processing (glutamine/glutamate
signaling, axonal development), inﬂammatory pathways, and
hypersensitivity/allergy in comparison with age-matched
controls.27 Although genomic and micro RNA–based diagnosis
of ﬁbromyalgia is not yet clinically validated or routine
standard of care, it is evident that ﬁbromyalgia is a “real
problem” where science has not yet reached the ability to
accurately diagnose the disease. Perhaps, most importantly, is
that ﬁbromyalgia often gets misused as a last-resort diagnosis or
a diagnosis of exclusion. Patients who claim to have a diagnosis
of ﬁbromyalgia may not actually have ﬁbromyalgia at all. In the
2012 National Health Interview Survey, almost 75% of persons
TABLE 1. Maneuvers for Sacroiliac Joint Syndrome Physical
Examination.
Clinical Maneuver Motion
Distraction Pressure on anterior superior iliac crest
Thigh thrust Adduction of ﬂexed affected hip
Compression Compression of the thigh from lateral position
Fortin ﬁnger Pt places 1 ﬁnger on source of pain 2 times
FABER (Patrick) Flexion, abduction, external rotation of the
thigh/hip
Gaenslen Hip hyperextension
Gillet Standing thigh ﬂexion
If ≥ 3 of the above tests are positive, sensitivity and speciﬁcity
range from 78% to 79% and 85% to 94%, respectively for the diagnosis
of sacroiliac joint syndrome.
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in the US population reporting a clinical diagnosis of ﬁbro-
myalgia failed to actually meet diagnostic criteria!28
Similar to ﬁbromyalgia, chronic lyme disease (CLD), has
nonspeciﬁc symptomatology and limited objective physical
examination and laboratory evidence by which diagnosis is
made.29 Much like ﬁbromyalgia, the term “chronic lyme dis-
ease” is fraught with confusion and misinformation. Lyme
disease, when untreated, can lead to disseminated lyme disease
weeks later with meningoradiculitis, facial palsy, encephalitis,
or even lyme carditis. Years of untreated lyme disease, can lead
to chronic borreliosis, including chronic destructive arthritis and
acrodermatitis chronica atrophicans.30 Particularly challenging
is that the diagnosis of lyme disease is less than ideal. Current
standard of care is to use clinical examination and history such
as exposure to ticks in a geographic known to carry Borrelia
burgdorferi along with a characteristic erythema migrans rash.
Objective diagnosis typically requires a 2-tier serological
approach with a sensitive ELISA test and conﬁrmatory Western
blot analysis which is more speciﬁc. Because these tests rely on
the body’s immune response, sensitivity is reliable in the later
stages of lyme disease, but may be only 35% sensitive in early
stages.31 However, untreated lyme disease with late, nonacute
symptoms is not synonymous with “chronic lyme disease.”
“Chronic lyme disease” is a phrase that has been used by
patients or a small number of health care providers to patients
with various nonspeciﬁc symptoms, including those with no
objective evidence of lyme disease. These patients jump on the
reality that current diagnostic methods of lyme disease have
limited sensitivity in early stages and jump on this “termed”
diagnosis. In some cases, neoplasms have been misdiagnosed
and actual treatment was delayed due to a claimed diagnosis of
CLD.32
In 2018, the evaluation of SI joint pain must be undertaken
with caution. Just as many patients claiming to have ﬁbro-
myalgia do not actually have ﬁbromyalgia, patients reporting
vague muscle pain in the buttock region or low back region
should not automatically be assumed to have SI joint dys-
function. Likewise, SI joint dysfunction is not a diagnosis of
exclusion. If no etiology for a patient’s low back pain or but-
tock can be identiﬁed, they should be told that there is no
diagnosis that can be identiﬁed to the best of our medical sci-
ence. Practically speaking, SI joint dysfunction has potential
overlap with lumbar spinal pathology and degenerative hip
disease. Clearly, patients should ﬁrst be ruled out for these
issues. Traditional imaging has not yet been proven to be
informative, however single photon emission computed
tomography (SPECT-CT) may be informative in cases where
objective imaging is considered.33 Intra-articular injections may
be helpful in diagnostic testing, although CT-guided injections
have been reported to be superior in accuracy to ﬂuoroscopic
guidance34 and may provide sufﬁcient therapeutic response.35
Sacral branch blocks may provide added diagnostic beneﬁt,
although the therapeutic beneﬁts are not as clear.36
SURGICAL TREATMENT
As is the case with the previously discussed syndromes of
ﬁbromyalgia and CLD, the lack of clear diagnostic markers for
SI joint syndrome makes interpreting the literature on surgical
treatment difﬁcult. Some patients diagnosed with SI joint dys-
function and subsequently treated in some studies, were likely
misdiagnosed. Moreover, one cannot image the SI joint post-
procedure to assess for differences as SPECT-CT has been the
only diagnostic imaging to correlate with preoperative
symptoms—postoperative SPECT-CT ﬁndings are unclear.
Some ablative procedures37,38 and anesthetic procedures10,39
have been reported with some efﬁcacy. In the Cohen et al38
radiofrequency ablation trial which studied patients with
> 75% pain relief lasting 6 hours or longer after a single SI joint
injection, the target was not the SI joint but the S1-S3 nerve
foramina and in the Patel et al trial,37 patients with a reduction
of > 75% relief of their index pain for at least 4 hours and up to
7 days following a diagnostic intra-articular injection were
randomized and found to have sustained pain relief in 47%
(n= 16) of treatment group and in 12% of the sham control
group at 3 months. A poor response of just 47% with sustained
pain relief raises questions about the usefulness of these pro-
cedures; however, other studies using CT guidance have shown
almost 90% success rates with intra-articular injections with
2-year follow-up.40
Review of the literature for surgical treatment is equally
challenging. Surgical fusion of the SI joint has a long history
dating back to 1908 with Painter’s41 posterior approach. This
was modiﬁed by Smith-Petersen42 to a lateral approach through
the ilium with screw ﬁxation. In these studies, the indications
for fusion were gross instability from fracture and tubercular
invasion of the joint for Painter41 and chronic infection,
tuberculosis, and “relaxation of the SI joint,” for Smith-
Petersen.42 The techniques have been adapted to MIS techni-
ques with ﬂuoroscopically guided placement of triangular
plasma coated titanium implants across the joint.43 These MIS
surgeries offer minimal soft tissue disruption, 3-cm incisions,
shorter hospital stays, higher rates of fusion (the use of BMP
aids in this),44 diminished recovery times, and better clinical
results.
The outcome reports of the MIS techniques have largely
been industry funded. Rudolf,43 in a retrospective study, report
improvement of postoperative pain scores of 70% to 85% at
1 year after unilateral joint fusion in 46 patients treated for
chronic degenerative sacroiliitis or SI joint disruption using an
immediate reduction of ≥ 75% in Visual Analog Scale pain
scales after image-guided diagnostic block, history, and
examination. Similarly, a large industry-funded case control
series by Polly et al45 reports 81.4% of surgical patients report
improvement in pain scores of ≥ 2 mm on the Visual Analog
Scale at 6 months and 83% of surgical patients report the same
improvement at 24 months.46 The inclusion criteria for the
Polly trial are a source of controversy as there were no SI joint
structural criteria, the intra-articular injection inclusion criteria
of “at least a 50% transient decrease in SIJ pain 30 to
60 minutes after image-guided local anesthetic injection into the
SIJ,” do not match what has been published in the literature
(discussed above),37,38 and the clinical diagnosis was non-
speciﬁc. Complicating the interpretation of these positive sur-
gical trials is Schutz and Grob’s47 series of 17 patients with
negative results in which 82% of patients report worsening or
no change in their pain score at last follow-up; however, Schutz
and Grob’s surgical intervention was bilateral, open surgery
with decortication and placement of local bone grafting for
chronic degenerative SI joint syndrome.
The dramatic discrepancy between Schutz and Grob’s
results and the MIS studies should raise red ﬂags in the sur-
geon’s mind. From the standpoint of SI “fusion” for a mobile
joint as a pain generator (an unveriﬁed, hypothesized mecha-
nism for SI joint syndrome is abnormal motion in the joint21), it
is hard to imagine why open technique would have such poor
results in contrast to MISs. Although soft tissue damage and
early postoperative pain is a given, one would expect open SI
fusion surgery to have good or even better long-term outcomes
secondary to superior bony fusion in the same way an open
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anterior lumbar interbody fusion offers superior fusion rates to
minimally invasive transforaminal interbody procedures; how-
ever, if we look back to our original discussion about the his-
torical treatment of disc herniation, it is certainly possible that
the strategies for surgical treatment used in 2018 are ﬂawed.
Fusion or actual bridging bone across the SI joint may correlate
with improvement SI joint pain, but it may not be essential to
the speciﬁc mechanism by which treatment provides relief. In
one of the present authors own practice (A.D.), a non–industry-
funded study of SI joint pain diagnosed by CT-guided injec-
tions and treated with MIS triangular titanium implants over a
5-year period showed 19 of 20 successes. Despite the fact that
fusion of the SI joint has been practiced for > 100 years, it
seems paradoxical to say it is in its infancy; however, in the
current era of evidenced-based medicine, the surgical fusion of
the SI joint for SI joint syndrome is so. There are few pro-
spective randomized control trials. There is still argument
among surgeons over diagnostic criteria for the diagnosis,
indications for the procedure, and optimal technique. Proce-
dures that treat the SI joint may not be directly comparable in
outcomes and surgeons must look to the literature when con-
sidering surgical options.
ETHICS
Surgery is a conservative and slowly evolving ﬁeld.
Innovation in surgical practice typically arises from slow
change in practice patterns over generations of surgeons with
slight variations in technique becoming standardized after a
time. Typically, these changes are minute—cortical sparing
amygdalohippocampectomy instead of radical temporal lobec-
tomy; percutaneous pedicle screw placement instead of open
ﬁxation; use of PEEK cages in anterior cervical discectomy and
fusion instead of iliac crest graft.
Radical change in surgical practice is rare and is almost
always fraught with controversy. The most notable examples
are in transplant surgery: Baby Fae and Lewis Washkansky, for
example. These 2 cardiac transplant patients were recipients of
new procedures bourne out of meticulous research and study.
Concurrent with these surgical advances were medical advances
to support the surgical innovation—transplant surgery was not
possible without advances in immunosuppressive therapies and
signiﬁcant advances in critical care. When these surgical
innovations were proposed to the world, they heralded broad
applicability, and unfortunately, they exacted a toll of human
life. They were, however, targeted at readily identiﬁable disease
processes. Baby Fae’s baboon heart was placed because of
hypoplastic left heart syndrome, the diagnosis of which is
unassailable; Washkansky’s human-to-human heart transplant
was undertaken because of his congestive heart failure, after
much evaluation by several surgeons and cardiologists prac-
ticing in South Africa.
To assess the ethical ﬁeld surrounding a new, innovative
surgical procedure, several considerations must be made. The
scientiﬁc underpinnings of the procedure must be assessed, the
ﬁeld strength of the innovators and system in which the inno-
vation is introduced, and the fallacy of desperate measures must
be considered.48
The scientiﬁc background supporting a surgical innova-
tion must be solid—that is the technique needs to be backed up
with extensive research into the anatomy and physiology of a
condition. This includes biological laboratory research into the
pathophysiology of a disease state and treatments.48–50 In deep
brain stimulation (DBS) for Parkinson’s disease, years of ani-
mal experimentation with development of animal models of the
diseases have preceded treatments. As the indications for DBS
expand, any expansion is preceded by extensive animal studies
of the pathology and treatment of proposed DBS indications
and targets. The funding agencies for the proposed expansion
indications commission ethical studies on the use of DBS in
those diseases. To date, for SI joint fusion using laterally
implanted stand-alone fusion cages, there are 2 published
cadaveric biomechanical studies.51,52
Field strength is a complex concept, well-described by
Moore with regard to transplant surgeries in the end of the last
century.48 The ﬁeld strength of a particular institution for a
particular type of surgical innovation lies not only in the sur-
gical skill, but also in the experience of the hospital team to
assist the surgeon in the preoperative and postoperative care of
the patient. For transplant surgery, not only is the skill of the
surgeon important, but the preoperative patient evaluation and
selection, postoperative ICU management, and postoperative
immunosuppressive therapy and monitoring are all critical in
the overall success of the procedure and are components of ﬁeld
strength.48,49 The ﬁeld necessary for successful SI joint fusion
may not be as complex as what is required for organ trans-
plantation, but it is important to consider.
The fallacy of desperate measures indicates that a patient
who is suffering—be it from liver failure, progressive impairing
tremor, or back pain limiting activity and function—will be
more apt to consider a therapy if there is a promise of allevi-
ation of that suffering, despite limited chances of success. The
following illustrates this concept well:
The surgeon should be aware of the fact that patients
threatened by severe illness display a surprising and sometimes
alarming readiness to accept uncertainty and reach out for
something new. The surgical scientist must avoid exploiting this
willingness of patients to try something new in a desperate
situation… This judgment should not be left to the patient, who
will always seek new hope and new treatment in a desperate
situation, but who lacks scientiﬁc background to make this
judgment.50
Although Moore was discussing severe illness, the argu-
ment applies to back pain which inhibits function causing
sufﬁcient suffering to patients, making them more willing to
consider any treatment that might provide relief, regardless of
how limited that relief might be. SI joint fusion offers that dim
glimmer of hope for relief, should the diagnosis of SI joint
syndrome in that particular patient be accurate.
When evaluating surgical fusion of the SI joint as a
treatment for a syndrome, the preponderance of evidence points
to the procedure being unvalidated. Clearly, there are cases in
which patients beneﬁted from surgery and the literature for
successes with MIS procedures is growing rather than shrink-
ing. Symptom alleviation in that group of patients is convincing
enough to underscore SI joint syndrome as an etiology. It is a
real diagnosis. However, using surgery as diagnostic con-
ﬁrmation is unacceptable. SI joint pain is never a diagnosis of
exclusion.
The temptation here is to throw the procedure out with the
bath water. There are patients who will beneﬁt from SI joint
fusion. Frank discussion and informed consent between the
clinician and the patient undergoing evaluation for SI joint
surgery is imperative. That discussion should include the reality
that the diagnostic criteria is still debated; that the surgical
results are not entirely predictable; that there are few data
available about the efﬁcacy of this procedure that is not industry
sponsored; that perioperative complications proﬁles can be high
with a high learning curve—20% in 1 series43; that the most
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comprehensive case control trial (industry sponsored) had
minimal subjective pain reduction as a measure of efﬁcacy45,46;
and that the clinical data are variable with some studies report
worsening of symptoms (which highlights the fact that not all
SI surgeries are the same).47
Exercise of caution and restraint are in order when rec-
ommending this unvalidated procedure. Patients trust surgeons
to be conservative—and the use of terms like innovative to
describe a procedure only intimate the truth that a procedure is
unproven. To respect the principles of autonomy, beneﬁcence,
and nonmalfeasance, full disclosure is imperative.
PRACTICAL CONSIDERATIONS
How then, does a conscientious surgeon, availing oneself
to aiding patients, proceed?
SI joint syndrome is easy to diagnose when all clinical
criteria are met and patients have a positive response to diag-
nostic blocks—but when the symptoms overlap and workup is
incomplete or inaccurate, treatment and diagnosis become
difﬁcult—it is worth bearing in mind that the prevalence of the
disease is at best 30% in patients presenting for evaluation of
low back pain.11,13–15 Importantly, the clinical examination by
which SI joint syndrome is diagnosed is unreliable and the
addition of further clinical maneuvers (Table 1) does not narrow
in on the diagnosis—there are logical and statistical fallacies of
signiﬁcance associated with the addition of variables. Extract-
ing the ﬁner points of a patient history to distinguish SI joint
syndrome from other causes of low back pain may require more
time than available in an initial patient visit.
Diagnostic treatments have limited accuracy and pre-
cision. Repeat injections in the face of an initial diagnostic test
are reasonable—but bear in mind that CT-guided injections are
only accurate in 60% to 70% of cases.10,12 Consideration must
also be given to inﬂating the radiation load to which a patient is
exposed—spine patients certainly see CT scanners frequently.
Moreover, as is the case for all other spine disorders, the
presence of the disorder is not a mandate for surgical treatment.
The treatment of advanced abdominal cancers is informative
here—because the capacity to diagnose a disease which may be
surgical exists does not at all mean that it should be surgically
treated.
One principle of the scientiﬁc method and its daughter,
evidence-based medicine, is that the algorithms developed to
treat a particular condition today will certainly change as the
understanding of a given disease progresses. Therefore, one
must be willing to kill one’s darlings and build new approaches
as the science underpinning the clinical art is revealed. If, at the
end of an extensive workup to rule out other etiologies such as
lumbar spinal pathology and hip osteoarthritis, the diagnosis
suggests SI joint dysfunction, it is reasonable to inform a patient
of the uncertainty surrounding the diagnosis, and to present
them a rational treatment plan with minimized risk. It is
important to emphasize to the patient that SI joint dysfunction is
never a diagnosis of exclusion, and before even undertaking
diagnostic injections, the patient’s level of pain and disability
should be considered. If the pain is merely “annoying” or rare,
patients should be counseled on activity modiﬁcation, use of
over-the-counter NSAIDs, given that there is no long-term
consequence of SI joint “annoyance,” the potential excess
radiation exposure and health care utilization costs is not
recommended.
Activity modiﬁcation is truly the standard of care for SI
joint syndrome. When a patient has tolerable symptoms that do
not reduce daily or recreational activities, then avoidance of
activities that exacerbate presenting symptoms are to be
avoided. Because of the SI joint’s unique anatomy, degener-
ation is inevitable—and symptomatic joint degeneration is
expected and normal. When that is the case, there is no rush to
proceed with surgical intervention. Counseling patients away
from acting on a known diagnosis under the fallacy of desperate
measures can prevent them from being harmed by treatments
which may not be indicated—lumbar fusion for SI joint syn-
drome, for example, which is ineffective.
If a patient is being treated with opiates from a referring
source, evaluation and treatment considerations change. Long-
term outcomes of spine disorders in the presence of opiate use
are poor.1,53 Moreover, if symptoms are impacting daily and
recreational activities and are becoming problematic to func-
tion, further investigation is warranted. These are patients who
should be proactively evaluated for SI joint dysfunction.
As discussed extensively above, the physical examination
for SI joint syndrome is unreliable and we do not recommend
its use as sole indication for surgery. Clarifying the diagnostic
criteria for SI joint syndrome is certainly critical; however,
doing so is beyond the scope of the current discussion. The
ethical principle of patient autonomy dictates that they be
provided with adequate information to make a decision: they
certainly should be informed that the diagnosis of SI joint
syndrome is problematic and that the primary method of
diagnosis, physical examination and clinical history, is unreli-
able. A leaping off point for diagnosis would be diagnostic
injections—but this route is not entirely benign. CT-guided
injection may be more accurate than ﬂuoroscopic injection
based upon seemingly higher outcomes in noncomparative
studies,34,40,54 but brings with it elevated radiation risk. Even
our best diagnostic tool is only 70% accurate55,56 and is
therefore, not ﬁnal.
When surgery is being considered, it is imperative to work
closely with the physician who is performing the diagnostic
tests. Knowledge of their technique and reassurance that
patients have had the inaccuracies of the procedures explained
to them is important. Patients also should be informed that false
positive responses can occur and even technically well-
performed SI surgeries with no clear “failure” will not have
100% success rates.
Discussing the surgical procedure with patients in appro-
priate detail is, as always, the key. Patients should know that
open SI joint surgery has poor results, and though the surgery
itself is not technically difﬁcult, the major studies showing
signiﬁcant improvement in outcomes have predominantly been
industry funded. Owing to the discrepancy between open SI
outcomes and MIS outcomes, it is important the surgeons be
familiar with the published literature for their implant of choice
and the discussion of the long-term outcomes, if any, are
available for that speciﬁc implant. Informed consent for this
procedure includes a discussion that failure may occur at
“n+1 day” of what has been published and that techniques and
implants continue to evolve. In this discussion, patients should
know that the postoperative treatment has yet to be optimized
speciﬁcally in terms of appropriate weight bearing restrictions
(if any), duration of these restrictions as well as any anti-
coagulation that may be beneﬁcial. Reassurance of long lasting
to commitment to treat potential complications arising from this
procedure is the duty of any surgeon performing this procedure.
As SI joint surgery is an uncommon procedure, patients should
be informed of this and surgeons should be well-trained before
undertaking this procedure. As always, a well-informed and
honest physician/patient discussion prepares both for any
outcome.
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FINAL CONCLUSIONS
In summary, existing or possible diagnoses of SI joint
syndrome should be viewed with healthy skepticism, but not
entirely discounted. Maintaining a diagnostic differential and
adapting or developing a treatment plan accordingly is just
good doctoring. SI joint is not a diagnosis of exclusion. Primum
No Nocere. Moreover, providing patient with the dignity of
choice empowers the patient and the physician to proceed—SI
joint fusion for the indication of pain is an elective procedure
with activity modiﬁcation as the standard of care. And should
surgical intervention be considered, surgeons must know the
literature for their preferred implant and be prepared and well-
trained on their preferred implant—there is, after all, a moral
imperative to surgical competence.
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